KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Quest Diagnostics (DGX) over the last 13 years, with Sep 2025 value amounting to $2.0 million.

  • Quest Diagnostics' Gains from Investment Securities rose 133.33% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.0 million, marking a year-over-year increase of 247.83%. This contributed to the annual value of -$41.0 million for FY2024, which is 197.62% down from last year.
  • Per Quest Diagnostics' latest filing, its Gains from Investment Securities stood at $2.0 million for Q3 2025, which was down 95.24% from $42.0 million recorded in Q1 2025.
  • In the past 5 years, Quest Diagnostics' Gains from Investment Securities registered a high of $42.0 million during Q1 2025, and its lowest value of -$60.0 million during Q2 2022.
  • In the last 3 years, Quest Diagnostics' Gains from Investment Securities had a median value of $2.0 million in 2025 and averaged $5.6 million.
  • Per our database at Business Quant, Quest Diagnostics' Gains from Investment Securities tumbled by 6,100.00% in 2022 and then skyrocketed by 227.27% in 2025.
  • Quest Diagnostics' Gains from Investment Securities (Quarterly) stood at $6.0 million in 2021, then plummeted by 583.33% to -$29.0 million in 2022, then soared by 148.28% to $14.0 million in 2023, then crashed by 128.57% to -$4.0 million in 2024, then soared by 133.33% to $2.0 million in 2025.
  • Its Gains from Investment Securities stands at $2.0 million for Q3 2025, versus $42.0 million for Q1 2025 and -$4.0 million for Q4 2024.